Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-16 Halfon Jean Michel Director Option exercise · Restricted Share Units −2,780 0
2019-05-16 Elstein Amir Director Option exercise +2,780 1,998,648
2019-05-16 Elstein Amir Director Option exercise · Restricted Share Units −2,780 0
2019-05-16 Crane Rosemary A Director Option exercise +2,780 10,792
2019-05-16 Crane Rosemary A Director Option exercise · Restricted Share Units −2,780 0
2019-05-16 BARER SOL J Director Option exercise +2,780 4,942
2019-05-16 BARER SOL J Director Option exercise · Restricted Share Units −2,780 0
2019-03-18 O'Grady Brendan P. EVP, North America Commercial Sale −1,179 $16.63 $20K 1,388.49
2019-03-18 Nazzi Gianfranco EVP, Growth Markets Commercial Sale −320 $16.64 $5K 9,002.36
2019-03-18 Daniell Richard Exec. VP, European Commercial Sale −1,297 $16.64 $22K 0
2019-03-18 Stark David Matthew Exec. VP Chief Legal Officer Sale −2,358 $16.43 $39K 2,974.39
2019-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,179 2,567.49
2019-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,179 1,179
2019-03-17 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +872 9,322.36
2019-03-17 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −872 874
2019-03-17 Daniell Richard Exec. VP, European Commercial Option exercise +1,297 1,297
2019-03-17 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −1,297 1,297
2019-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +2,358 5,332.39
2019-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −2,358 2,359

Page 64 of 64 · 1,279 trades